Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™
Altasciences, a leading drug development organization, today announced a significant milestone in the development ofSteel Therapeutics, Inc.’spivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant...